In the 1st quarter of 2025, fentanyl deaths are decreasing in the US. The sudden drop is the first in decades. Unfortunately, xylazine, also known as the zombie drug, may be posing an increasing threat.
For years, drug overdose deaths in the U.S. had been on the rise. This year, data indicates a sudden decline.
President Donald Trump claims his move to increase tariffs is part of a larger strategy to control the influx of drugs across the US borders. He says it is a vital tool used to reduce the amount of illicit fentanyl entering the U.S.
A Shift in Overdose Trends
For years, drug overdose deaths in the U.S. had been escalating, primarily due to the proliferation of synthetic opioids like fentanyl. Recent data indicates a sudden decline in these fatalities.
President Donald Trump attributes this reduction to his administration’s strategy of increasing tariffs, aiming to curtail the influx of illicit fentanyl across U.S. borders.
Emergence of the Zombie Drug
Xylazine, a veterinary tranquilizer not approved for human use by the U.S. Food and Drug Administration, has emerged as a significant concern.
